Nielsen B, Mikkelsen C, Oturai P, Krogh-Madsen R, Katzenstein T, Ritz C
Front Endocrinol (Lausanne). 2024; 15:1382241.
PMID: 39530118
PMC: 11550925.
DOI: 10.3389/fendo.2024.1382241.
Bestas A, Unal E, Aktar Karakaya A, Beyazit N, Savas S, Sen V
Sisli Etfal Hastan Tıp Bul. 2024; 58(3):389-394.
PMID: 39411039
PMC: 11472201.
DOI: 10.14744/SEMB.2024.65983.
Nielsen B, Mathiesen I, Krogh-Madsen R, Katzenstein T, Pressler T, Shaw J
Diabetologia. 2024; 67(10):2188-2198.
PMID: 39093413
PMC: 11447061.
DOI: 10.1007/s00125-024-06220-6.
Scully K, Marks B, Putman M
Diabetologia. 2024; 67(10):2143-2153.
PMID: 38995399
DOI: 10.1007/s00125-024-06223-3.
Wu M, Davis J, Zhao C, Daley T, Oliver K
J Clin Transl Endocrinol. 2024; 36:100344.
PMID: 38765466
PMC: 11099334.
DOI: 10.1016/j.jcte.2024.100344.
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis.
Kirigin Bilos L, Altabas V, Vukic Dugac A, Baretic M
Medicina (Kaunas). 2024; 60(3).
PMID: 38541202
PMC: 10972086.
DOI: 10.3390/medicina60030477.
Early-phase insulin secretion during mixed-meal tolerance testing predicts β-cell function and secretory capacity in cystic fibrosis.
Sheikh S, Stefanovski D, Kilberg M, Hadjiliadis D, Rubenstein R, Rickels M
Front Endocrinol (Lausanne). 2024; 15:1340346.
PMID: 38444582
PMC: 10912512.
DOI: 10.3389/fendo.2024.1340346.
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.
Liou T, Argel N, Asfour F, Brown P, Chatfield B, Cox D
iScience. 2024; 27(3):108835.
PMID: 38384849
PMC: 10879674.
DOI: 10.1016/j.isci.2024.108835.
Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
Malik S, Padmanabhan D, Hull-Meichle R
Front Endocrinol (Lausanne). 2023; 14:1269139.
PMID: 38075070
PMC: 10704027.
DOI: 10.3389/fendo.2023.1269139.
Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy.
Flatt A, Sheikh S, Peleckis A, Alvarado P, Hadjiliadis D, Stefanovski D
J Clin Endocrinol Metab. 2023; 109(1):151-160.
PMID: 37503734
PMC: 10735317.
DOI: 10.1210/clinem/dgad443.
Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response.
Sebastian-Valles F, Arranz Martin J, Giron R, Knott-Torcal C, Sampedro-Nunez M, Martin-Adan J
Biomedicines. 2023; 11(6).
PMID: 37371849
PMC: 10296576.
DOI: 10.3390/biomedicines11061754.
CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes.
Alexandre-Heymann L, Puerto M, Martin C, Burnet E, Mosnier-Pudar H, Burgel P
Sci Rep. 2023; 13(1):10433.
PMID: 37369827
PMC: 10300009.
DOI: 10.1038/s41598-023-37492-4.
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman M, Norris A, Hull R, Rickels M, Sussel L, Blackman S
Diabetes Care. 2023; 46(6):1112-1123.
PMID: 37125948
PMC: 10234745.
DOI: 10.2337/dc23-0380.
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman M, Norris A, Hull R, Rickels M, Sussel L, Blackman S
Diabetes. 2023; 72(6):677-689.
PMID: 37125945
PMC: 10202770.
DOI: 10.2337/db22-0949.
Diagnosis and Management of Cystic Fibrosis Exacerbations.
Milinic T, McElvaney O, Goss C
Semin Respir Crit Care Med. 2023; 44(2):225-241.
PMID: 36746183
PMC: 10131792.
DOI: 10.1055/s-0042-1760250.
Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis.
Chan C, Granados A, Moheet A, Singh S, Vigers T, Arbelaez A
J Clin Transl Endocrinol. 2023; 30:100311.
PMID: 36620757
PMC: 9816065.
DOI: 10.1016/j.jcte.2022.100311.
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents.
Ode K, Ballman M, Battezzati A, Brennan A, Chan C, Hameed S
Pediatr Diabetes. 2022; 23(8):1212-1228.
PMID: 36537525
PMC: 10108242.
DOI: 10.1111/pedi.13453.
The experience of living with and managing cystic fibrosis related diabetes: a qualitative review.
Collins S, Jones A, Woodward S, Sturt J
J Res Nurs. 2022; 27(8):735-753.
PMID: 36530741
PMC: 9755567.
DOI: 10.1177/17449871221116970.
Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
Tanner K, Daniel R, Bilton D, Simmonds N, Sharples L, Keogh R
Diabet Med. 2022; 39(11):e14958.
PMID: 36075586
PMC: 9826418.
DOI: 10.1111/dme.14958.
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S, Rowbotham N, Charbek E
Cochrane Database Syst Rev. 2022; 8:CD008319.
PMID: 35914011
PMC: 9342853.
DOI: 10.1002/14651858.CD008319.pub4.